Impact BioMedical, Inc. - Kewajiban jangka dawa perusahaan IBO

The available price action for Impact BioMedical Inc (IBO) reflects the dynamics of a company integrating ESG standards into its project management for combating viruses and bacteria. However, the lack of recurring revenue and a dependence on investments create significant risks, with long-term debt amounting to 0.00. The business relies on a diversified patent portfolio, including sugar substitutes, monetizing licenses across various medical segments.

This indicator mathematically reflects the ability of cash flows to service long-term loans. The metric measures total liabilities with a maturity of more than one year, determining the level of financial leverage. For Impact BioMedical Inc (IBO), such loans often fund a highly qualified research staff and the development of innovations. By analyzing the size of the issuer's long-term liabilities, an investor assesses the business model's resilience to changes in interest rates.